Literature DB >> 30190934

Impact of a shortened surveillance interval on hepatocellular carcinoma survival.

Do Young Kim1, Kwang-Hyub Han1.   

Abstract

Entities:  

Year:  2013        PMID： 30190934      PMCID： PMC6114001          DOI： 10.2217/hep.13.1

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  10 in total

1.  Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities.

Authors:  Jean-Claude Trinchet; Cendrine Chaffaut; Valérie Bourcier; Françoise Degos; Jean Henrion; Hélène Fontaine; Dominique Roulot; Ariane Mallat; Sophie Hillaire; Paul Cales; Isabelle Ollivier; Jean-Pierre Vinel; Philippe Mathurin; Jean-Pierre Bronowicki; Valérie Vilgrain; Gisèle N'Kontchou; Michel Beaugrand; Sylvie Chevret
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

2.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

3.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

Authors:  L Bolondi; S Sofia; S Siringo; S Gaiani; A Casali; G Zironi; F Piscaglia; L Gramantieri; M Zanetti; M Sherman
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

Authors:  Valentina Santi; Franco Trevisani; Annagiulia Gramenzi; Alice Grignaschi; Federica Mirici-Cappa; Paolo Del Poggio; Maria Anna Di Nolfo; Luisa Benvegnù; Fabio Farinati; Marco Zoli; Edoardo Giovanni Giannini; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Mauro Bernardi
Journal:  J Hepatol       Date:  2010-04-27       Impact factor: 25.083

5.  Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Authors:  Franco Trevisani; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Luisa Benvegnù; Marco Zoli; Gian Luca Grazi; Poggio Paolo Del; NolfoMariaAnna Di; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

6.  A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus.

Authors:  Elena Santagostino; Massimo Colombo; Monica Rivi; Maria Grazia Rumi; Angiola Rocino; Silvia Linari; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

7.  Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.

Authors:  Jing-Houng Wang; Kuo-Chin Chang; Kwong-Ming Kee; Pao-Fei Chen; Yi-Hao Yen; Po-Lin Tseng; Yuan-Hung Kuo; Ming-Chao Tsai; Chao-Hung Hung; Chien-Hung Chen; Wei-Chen Tai; Lin-San Tsai; Shu-Chuan Chen; Sheng-Che Lin; Sheng-Nan Lu
Journal:  Am J Gastroenterol       Date:  2013-01-15       Impact factor: 10.864

8.  Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?

Authors:  Amit G Singal; Mahendra Nehra; Beverley Adams-Huet; Adam C Yopp; Jasmin A Tiro; Jorge A Marrero; Anna S Lok; William M Lee
Journal:  Am J Gastroenterol       Date:  2013-01-22       Impact factor: 10.864

9.  Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.

Authors:  Kwang-Hyub Han; Do Young Kim; Jun Yong Park; Sang Hoon Ahn; Jieun Kim; Seung Up Kim; Ja Kyung Kim; Kwan Sik Lee; Chae Yoon Chon
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.